Obstructive Sleep Apnea Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Obstructive Sleep Apnea stocks.

Obstructive Sleep Apnea Stocks Recent News

Date Stock Title
Nov 1 TEVA Teva long-acting olanzapine shows improvements in schizophrenia patients
Nov 1 TEVA Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Nov 1 TEVA Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well ...
Nov 1 TEVA Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Nov 1 RMD Boston Scientific Stock Gains From Market Expansion, Innovation
Nov 1 RMD PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis
Nov 1 TEVA EC fines Teva $502m over multiple sclerosis treatment Copaxone practices
Oct 31 TEVA Teva fined $500M by EU for disparaging rival MS drug (update)
Oct 31 RMD Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
Oct 31 TEVA EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Oct 31 RMD MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin
Oct 31 TEVA Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
Oct 31 TEVA Teva Statement on European Commission Decision; Company to Appeal
Oct 30 RMD Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket
Oct 30 RMD DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
Oct 30 INSP Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Oct 30 RMD Investors Shouldn't Overlook ResMed's (NYSE:RMD) Impressive Returns On Capital
Oct 30 INSP Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
Oct 29 RMD Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock
Oct 29 RMD ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock
Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway. It is characterized by repetitive episodes of shallow or paused breathing during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation. These episodes of decreased breathing, called "apneas" (literally, "without breath"), typically last 20 to 40 seconds.Individuals with OSA are rarely aware of difficulty breathing, even upon awakening. It is often recognized as a problem by others who observe the individual during episodes or is suspected because of its effects on the body. OSA is commonly accompanied with snoring. Some use the terms obstructive sleep apnea syndrome or obstructive sleep apnea–hypopnea syndrome to refer to OSA which is associated with symptoms during the daytime. Symptoms may be present for years or even decades without identification, during which time the individual may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Individuals who generally sleep alone are often unaware of the condition, without a regular bed-partner to notice and make them aware of their symptoms.
As the muscle tone of the body ordinarily relaxes during sleep, and the airway at the throat is composed of walls of soft tissue, which can collapse, it is not surprising that breathing can be obstructed during sleep. Although a minor degree of OSA is considered to be within the bounds of normal sleep, and many individuals experience episodes of OSA at some point in life, a small percentage of people have chronic, severe OSA.
Many people experience episodes of OSA for only a short period. This can be the result of an upper respiratory infection that causes nasal congestion, along with swelling of the throat, or tonsillitis that temporarily produces very enlarged tonsils. The Epstein-Barr virus, for example, is known to be able to dramatically increase the size of lymphoid tissue during acute infection, and OSA is fairly common in acute cases of severe infectious mononucleosis. Temporary spells of OSA syndrome may also occur in individuals who are under the influence of a drug (such as alcohol) that may relax their body tone excessively and interfere with normal arousal from sleep mechanisms.

Browse All Tags